Back to Search
Start Over
Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinson’s disease
- Source :
- Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
- Publication Year :
- 2018
- Publisher :
- Springer Science and Business Media LLC, 2018.
-
Abstract
- A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Details
- ISSN :
- 20452322
- Volume :
- 8
- Database :
- OpenAIRE
- Journal :
- Scientific Reports
- Accession number :
- edsair.doi.dedup.....64e72f30571d8b4f6728b22a01f45ef4
- Full Text :
- https://doi.org/10.1038/s41598-018-31455-w